Search…

Kaiser Pharmaceuticals-B (02171.HK) spent 4.8609 million Hong Kong dollars on December 23 to repurchase 320,000 shares.

23/12/2025

Zh tng cijng APP xn, k j yoy - B (02171.HK) fb gnggo, y 2025 nin 12 yu 23 r gi gngs ch z 486.09 wn gngyun hugu 32 wn g, hugu jig wi mi g 14.98-15.25 gngyun. Zhitong Financial APP News, Keji Pharmaceutical-B (02171.HK) announced that on December 23, 2025, the company spent 4.8609 million Hong Kong dollars to repurchase 320,000 shares, at a repurchase price of HK$14.98-15.25 per share.

Latest

2 m ago

American consumer confidence has fallen for the fifth consecutive month, with views on employment becoming more pessimistic.

4 m ago

President Trump of the United States: It is precisely based on the tax legislation I have promoted - that extraordinary and great law - as well as tariff policies, that investment levels are constantly breaking historical records. The Trump economic golden age is in full swing - the best is yet to come!

6 m ago

The castle investment will return 5 billion dollars to investors.

8 m ago

Saab Company: Signed a framework agreement with the Swedish Defense Materiel Administration for the compact radar system "Giraffe-1X" and received an order within the scope of the agreement. The order is worth approximately 650 million Swedish Kronor and will be delivered immediately.

10 m ago

Xu Kunlin and Wang Xinwei met with a group of investors from listed companies for investment investigation.

See all latest